Diagnostic testing errors can begin before a sample reaches the analyzer. A mislabeled tube, incomplete patient history, or delayed transport may quietly change the final clinical decision. This is why learning how to reduce errors in diagnostic testing requires attention to the entire testing pathway, not only laboratory equipment.
The World Health Organization reports that one in ten patients experiences harm in healthcare, with more than half considered preventable. The National Academies also warned that most people will experience at least one diagnostic error during their lifetime. In outpatient care, a BMJ study estimated that approximately 12 million American adults may be affected by diagnostic errors each year. These figures are not perfect measurements. Reporting systems still miss many near misses and delayed diagnoses. That limitation deserves attention.
Mark L. Graber, a leading diagnostic-safety researcher and founder of the Society to Improve Diagnosis in Medicine, defined diagnostic error as “the failure to establish an accurate and timely explanation of the patient’s health problem or to communicate that explanation to the patient.” His statement highlights a practical reality: accurate testing is not enough if results are misunderstood or poorly communicated. Effective error reduction therefore combines standardized patient identification, clear specimen-handling procedures, instrument quality controls, clinician-laboratory communication, and review of unexpected results. A barcode may prevent one labeling mistake. It cannot replace careful judgment. Reliable improvement depends on measuring failures, discussing them without blame, and redesigning weak steps before harm reaches the patient.
Diagnostic error means a missed, delayed, or incorrect diagnosis. The National Academies’ 2015 report estimated that about 5% of U.S. adults experience an outpatient diagnostic error each year. That equals roughly 12 million people annually. The figure is an estimate, not a perfect measurement. Outpatient records often lack a clear trail from symptoms to final diagnosis.
The definition matters because testing is only one part of diagnosis. A correct test can still be misunderstood, ignored, or ordered too late. AHRQ’s Patient Safety Network highlights failures in follow-up, communication, and result interpretation as recurring risks. In a clinic, one unanswered alert can sit beside a busy inbox for days. A patient may return with worsening fatigue, pain, or shortness of breath.
Safer practice requires visible ownership. Clinicians should document the working diagnosis, expected results, and next action before ordering a test. Staff need a reliable process for abnormal findings, including direct patient notification. Electronic reminders help, but they do not replace judgment. The 5% estimate should prompt careful review, not blame. It may also miss errors that patients never recognize. Better measurement remains necessary.
How to Reduce Errors in Diagnostic Testing?
Map the testing process before changing equipment or retraining staff. The pathway begins with the test request and ends with a reported result. It includes patient preparation, identification, specimen collection, labeling, transport, and accessioning. Published evidence places 46–68% of laboratory errors in preanalytical steps (Plebani, Clinical Chemistry and Laboratory Medicine, 2006). That figure deserves attention.
Small details create large risks. A mislabeled tube can begin with two patients waiting beside the same trolley. A delayed sample may sit for 40 minutes near a warm window. The map should record who acts, when, and under which conditions. The World Health Organization’s Guidelines on Drawing Blood stress patient identification, correct labeling, and controlled transport (WHO, 2010). These are simple actions. They are not always simple in practice.
Use direct observations, incident reviews, and staff interviews to test the map. Compare written procedures with real behavior. Lippi and colleagues reported that most laboratory errors occur outside the analytical phase, reinforcing the need for broader quality controls (Clinical Chemistry and Laboratory Medicine, 2011). Still, percentages can hide local problems. One hospital may struggle with hemolysis; another may struggle with incomplete requests. A useful map should show both. It should also be revised after near misses, not only after confirmed harm. We may believe the process is controlled. The specimen often tells a different story.
Diagnostic testing errors often begin before analysis. A mislabeled tube can produce a clinically polished, completely wrong result. Standardized identification reduces this risk at the patient’s bedside.
Use two independent identifiers, such as full name and date of birth. Ask the patient to state them, rather than confirming yes or no. Match those details with the request form and specimen label. Label each container immediately after collection. Do it in the patient’s presence. Never pre-label tubes on a crowded tray. For difficult collections, pause and ask another trained colleague to verify the process. This small interruption may prevent a serious mix-up.
Tips: Keep a clear identification checklist near the collection area. Use readable labels and document unusual events. Confirm the specimen type, collection time, and required storage conditions. Reject unclear specimens according to written policy. Explain the reason calmly to the clinical team.
Collection technique also matters. The wrong tube, insufficient volume, or delayed transport can distort results. Staff training should include practical demonstrations, not only online modules. Supervisors can review near misses without blame and look for repeated weak points. A rushed shift may still defeat a good procedure. That is worth examining. Sometimes the checklist is present, but difficult to reach or poorly designed. Feedback from patients and collectors can reveal these gaps before they become routine.
Diagnostic errors often begin before a sample reaches the laboratory. Decision support can help clinicians ask whether a test is necessary, timely, and clinically relevant. It may compare symptoms, examination findings, medical history, and pretest probability. A low-risk patient with mild, short-term symptoms may not need a broad testing panel. Fewer unnecessary tests can mean fewer false positives, extra appointments, and avoidable anxiety.
The system can also support interpretation after results arrive. It may flag unit differences, age-specific reference ranges, critical values, or results that conflict with the clinical picture. A positive result is not automatically a diagnosis. For example, testing a very low-risk patient can produce an unexpected finding that leads to imaging, referrals, or treatment without clear benefit. Clear explanations matter. Clinicians need to see why an alert appeared, not just receive a colored warning.
Decision support works best when built around current evidence, local protocols, and regular review by qualified professionals. It should encourage discussion, not replace it. Alerts can be poorly timed, overly sensitive, or based on incomplete records. That weakness deserves attention. A clinician may reasonably override an alert when a patient’s condition changes quickly or unusual features are present. The reason should be documented. Reviewing these overrides can reveal missed risks, unnecessary tests, and confusing guidance. Small design details matter, such as showing the patient’s previous results beside the current value.
A widely cited U.S. estimate suggests that about 795,000 people experience serious diagnostic errors each year. Many errors begin after the test, not during it. An abnormal result may sit unread in an inbox, while a patient assumes everything is fine. The safest response is a closed follow-up loop, with a named person responsible for every result.
Clinics can use daily result queues, clear escalation rules, and documented patient contact. A critical finding should trigger direct communication, not a passive portal message. Staff should record the date, method, recipient, and next action. If a patient misses an appointment, the system needs a second pathway, such as a phone call or mailed notice. Small details matter. “Left voicemail” is not the same as confirmed follow-up.
Independent review also helps. Teams can sample delayed results each month and compare them with appointment records. They should ask whether the test was appropriate, whether the report was understood, and whether the patient received understandable instructions. Technology can flag risk, but it cannot repair vague ownership. That remains a human weakness. Some workflows will still fail, especially during handoffs or staff shortages. Honest audits should examine those failures without blaming individuals. The goal is not perfect prediction. It is making missed results visible early enough to change care.
It is a missed, delayed, or incorrect diagnosis. A correct test can still be misunderstood or ignored. Testing is only one part of diagnosis.
One estimate suggests about 5% of U.S. adults experience an outpatient error yearly. That equals roughly 12 million people. The number is approximate, not exact.
Results may remain unread in a crowded electronic inbox. A patient may return with worsening fatigue, pain, or breathing difficulty. Follow-up failures are easy to overlook.
A named person should own every result until the next action is completed. Staff should document contact dates, communication methods, recipients, and instructions. Ownership must be visible.
Preanalytical steps may account for 46–68% of laboratory errors. These include patient identification, collection, labeling, transport, and registration. The tube often reveals the problem.
Two patients may wait beside the same collection trolley. A sample may sit for 40 minutes near a warm window. A mislabeled tube can invalidate later testing.
Use daily result queues, escalation rules, and documented patient contact. Critical findings need direct communication, not only a portal message. “Left voicemail” is not confirmed follow-up.
They can observe real work, interview staff, and review near misses. Compare written procedures with actual behavior. Honest review matters, because the process may look safer than it is.
No. Reminders can highlight risk, but they cannot replace judgment or clear ownership. Handoffs and staff shortages may still break the process. Perfect control is unlikely.
Reducing diagnostic errors requires a clear understanding of where failures occur throughout the testing process. Diagnostic error can involve a missed, delayed, or incorrect diagnosis, and estimates suggest that it affects a significant share of outpatient care. Because as many as 68% of laboratory mistakes may occur before analysis, healthcare organizations should carefully map each step, from ordering and patient preparation to specimen transport and reporting. Standardized patient identification, accurate labeling, and consistent specimen-collection procedures can help prevent mix-ups and improve reliability.
A practical approach to how to reduce errors in diagnostic testing also includes decision-support tools that guide appropriate test selection, limit unnecessary testing, and help clinicians interpret results in context. Finally, every abnormal or pending result should have a clearly assigned follow-up responsibility. Closing this communication loop can reduce delays, overlooked findings, and potential harm, especially given estimates of hundreds of thousands of serious diagnostic errors in the United States. Consistent processes, staff training, and regular review are essential for safer diagnostic care.
Medvok Medical